Celltrion (XKRX:068270) Total Liabilities : ₩3,475,160 Mil (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Celltrion Total Liabilities?

Celltrion's Total Liabilities for the quarter that ended in Dec. 2024 was ₩3,475,160 Mil.

Celltrion's quarterly Total Liabilities increased from Jun. 2024 (₩3,133,196.10 Mil) to Sep. 2024 (₩3,275,800.84 Mil) and increased from Sep. 2024 (₩3,275,800.84 Mil) to Dec. 2024 (₩3,475,160.07 Mil).

Celltrion's annual Total Liabilities increased from Dec. 2022 (₩1,617,448.04 Mil) to Dec. 2023 (₩2,831,019.52 Mil) and increased from Dec. 2023 (₩2,831,019.52 Mil) to Dec. 2024 (₩3,475,160.07 Mil).

Celltrion Total Liabilities Historical Data

The historical data trend for Celltrion's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Total Liabilities Chart

Celltrion Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

1,592,540.90

1,623,747.85

1,617,448.04

2,831,019.52

3,475,160.07

Celltrion Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															2,831,019.52	3,145,448.46	3,133,196.10	3,275,800.84	3,475,160.07

Celltrion Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Celltrion's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3187120.606	+	(105683.975	+	180518.425
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	1837.063)
	=	3,475,160

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	21055222.438	-	17580062.369
	=	3,475,160

Celltrion's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3187120.606	+	(105683.975	+	180518.425
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	1837.063)
	=	3,475,160

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	21055222.438	-	17580062.369
	=	3,475,160

Celltrion Total Liabilities Related Terms

Thank you for viewing the detailed overview of Celltrion's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Celltrion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840

Website

http://www.celltrion.com

Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion Headlines

No Headlines